Energy Active Product for Fatigue
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a new health product, Energy Active Product 1, can reduce fatigue and improve related health issues. It will compare the effects of the actual product against a placebo, which is a harmless pill resembling the real one but without an active ingredient. The trial seeks individuals who often feel tired and believe their fatigue could improve by at least 30%. Participants should reside in the U.S., be willing to take the product without knowing if it's real or a placebo, and must not have major health conditions like heart or kidney disease. As an unphased trial, this study provides a unique opportunity to contribute to understanding how this product might help reduce fatigue.
Will I have to stop taking my current medications?
You may need to stop taking certain medications if they interact with the study product, such as blood thinners, blood pressure meds, or antidepressants. It's best to discuss your current medications with the study team to see if any changes are needed.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research on the Energy Active Product 1 lacks detailed safety information. Available studies focus on the product's effects on tiredness but omit specific safety details. However, as this is an early-stage trial, the product has likely undergone some initial safety checks. Generally, treatments in later stages have demonstrated sufficient safety to continue testing. Although exact safety data is unavailable, the product's inclusion in this trial suggests it is expected to be safe. Prospective participants should discuss any concerns with a healthcare provider before participating.12345
Why are researchers excited about this trial's treatment?
Researchers are excited about the Energy Active Product for fatigue because it could offer a new way to tackle tiredness. Unlike traditional treatments that might rely on stimulants or lifestyle changes, this product is designed to work through a novel mechanism that targets the body's energy systems directly. This could mean a boost in energy without the typical jitters or crash associated with common caffeine-based options. If successful, it could offer a faster, more sustained energy lift for those struggling with fatigue.
What evidence suggests that this trial's treatments could be effective for fatigue?
This trial will compare Energy Active Product 1 with a placebo control to evaluate its effectiveness in reducing tiredness. Research suggests that Energy Active Product 1 might help alleviate tiredness. Previous studies have shown that some health and wellness products can positively affect tiredness and related health issues. Specifically, improvements appeared in people with moderate-to-severe tiredness, indicating possible benefits. Although specific data on Energy Active Product 1 remains limited, similar products work in ways that support its potential to help manage tiredness. Overall, early signs are promising, but more research is needed to confirm its effectiveness.678910
Who Is on the Research Team?
Susan Hewlings
Principal Investigator
Radicle Science
Are You a Good Fit for This Trial?
This trial is for individuals experiencing fatigue who are interested in testing the effects of health and wellness products. Specific eligibility criteria details were not provided, so it's assumed that participants should be generally healthy adults.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the study product or placebo for 7 weeks, with self-reported data collected electronically
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Energy Active Product 1
- Energy Product Placebo Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Radicle Science
Lead Sponsor